MindBio Therapeutics Corp.
MBIO
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 46.50K | 34.90K | 92.50K | 169.70K | 79.60K |
| Total Receivables | 42.00K | 40.30K | 37.00K | 33.90K | 21.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 88.50K | 75.20K | 129.60K | 203.50K | 101.30K |
|
|
|||||
| Total Current Assets | 88.50K | 75.20K | 129.60K | 203.50K | 101.30K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 88.50K | 75.20K | 129.60K | 203.50K | 101.30K |
|
|
|||||
| Total Accounts Payable | 411.30K | 413.40K | 352.10K | 339.50K | 311.00K |
| Total Accrued Expenses | 49.50K | 55.50K | 53.40K | -- | 30.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.12M | 3.41M | 3.35M | 701.50K | 720.90K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.58M | 3.87M | 3.76M | 1.04M | 1.06M |
|
|
|||||
| Total Current Liabilities | 3.58M | 3.87M | 3.76M | 1.04M | 1.06M |
| Long-Term Debt | -- | -- | -- | 2.60M | 2.69M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 192.10K | 215.30K | 207.20K | 228.20K | 238.60K |
| Total Liabilities | 3.78M | 4.09M | 3.96M | 3.87M | 3.99M |
|
|
|||||
| Common Stock & APIC | 3.53M | 3.80M | 3.66M | 3.50M | 3.66M |
| Retained Earnings | -8.16M | -8.88M | -8.51M | -8.22M | -8.64M |
| Treasury Stock & Other | 974.40K | 1.10M | 1.05M | 1.08M | 1.13M |
| Total Common Equity | -3.65M | -3.98M | -3.80M | -3.64M | -3.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.65M | -3.98M | -3.80M | -3.64M | -3.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -35.40K | -36.70K | -35.70K | -33.20K | -42.50K |
| Total Equity | -3.69M | -4.01M | -3.83M | -3.67M | -3.89M |
|
|
|||||
